https://www.marketscreener.com/quote/stock/ONO-PHARMACEUTICAL-CO-LTD-6492021/news/ONO-PHARMACEUTICAL-Five-Year-Survival-Observed-With-Opdivo-nivolumab-in-Patients-With-Previously-24161312/?utm_source=telegram&utm_medium=social&utm_campaign=share